Zytiga 500 mg Film-Coated Tablets (Abiraterone Acetate)

Overview: Zytiga 500 mg (Abiraterone Acetate)

Zytiga 500 mg, containing the active ingredient Abiraterone Acetate, is a specialized oncology medication developed by Janssen. It is classified as an inhibitor of CYP17, an enzyme essential for the production of androgens, which are known to fuel the growth of prostate cancer cells.

Mechanism and Clinical Utility

Zytiga works by selectively inhibiting the CYP17 enzyme, effectively reducing androgen production throughout the body. By lowering androgen levels, Zytiga helps to slow the progression of metastatic prostate cancer. This targeted therapy is a vital component of modern oncology regimens for patients requiring comprehensive disease management.

Key Therapeutic Benefits

• Targeted CYP17 Inhibition: Highly specific action that targets the source of androgen production to effectively control tumor growth.
• Advanced Oncology Support: Designed to offer a precise treatment approach, providing essential support in managing metastatic prostate cancer.
• Clinical Reliability: Developed by Janssen, a globally recognized leader in oncology, ensuring high standards of therapeutic quality and efficacy.
• Precise Dosing: Provided as 500 mg film-coated tablets, supporting accurate and flexible treatment plans as determined by your oncology specialist.

Product Details and Usage

Zytiga 500 mg is provided in a 60-tablet supply per unit. This packaging is designed to support the specific dosing schedules required for effective long-term prostate cancer management, ensuring patients have consistent access to their prescribed therapy.

Safety and Storage Guidelines

Administration: Must be taken strictly as prescribed by your oncologist. Adjustments to therapy or dosing must be performed only by authorized medical professionals.
Storage: Store the tablets in their original packaging in a cool, dry place. Keep out of reach of children and ensure the storage environment remains within standard temperature limits.
Healthcare Collaboration: Maintain consistent communication with your oncology care team and the specialists at El-Masry Pharmacy to ensure optimal treatment outcomes and to address any clinical concerns promptly.

Disclaimer: Zytiga is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription and consult with your healthcare provider before beginning any treatment plan.